Dana Investment Advisors, Inc. Horizon Therapeutics Public LTD CO Transaction History

Dana Investment Advisors, Inc.

$2.99 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $421,132 - $768,150	-6,750 Reduced 11.68%	51,053 $5.81 Million
Q3 2022 Nov 15, 2022	SELL	$58.92 - $84.67 $16 Million - $23 Million	-272,188 Reduced 82.48%	57,803 $3.58 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $703,563 - $1.03 Million	-8,861 Reduced 2.62%	329,991 $26.3 Million
Q1 2022 May 12, 2022	BUY	$86.42 - $109.81 $90,654 - $115,190	1,049 Added 0.31%	338,852 $35.7 Million
Q4 2021 Feb 09, 2022	SELL	$98.56 - $119.91 $1.79 Million - $2.18 Million	-18,200 Reduced 5.11%	337,803 $36.4 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $1.1 Million - $1.32 Million	-12,005 Reduced 3.26%	356,003 $39 Million
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $1.8 Million - $2.01 Million	-20,903 Reduced 5.37%	368,008 $34.5 Million
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $16.8 Million - $22.3 Million	233,921 Added 150.93%	388,911 $35.8 Million
Q4 2020 Feb 11, 2021	BUY	$67.0 - $84.39 $1.92 Million - $2.42 Million	28,693 Added 22.72%	154,990 $11.3 Million
Q3 2020 Nov 10, 2020	BUY	$55.23 - $79.93 $4.56 Million - $6.59 Million	82,477 Added 188.22%	126,297 $9.81 Million
Q2 2020 Aug 11, 2020	SELL	$30.2 - $56.98 $418,602 - $789,799	-13,861 Reduced 24.03%	43,820 $2.44 Million
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $275,161 - $426,627	-11,064 Reduced 16.09%	57,681 $1.71 Million
Q4 2019 Feb 11, 2020	SELL	$25.43 - $36.67 $460,893 - $664,607	-18,124 Reduced 20.86%	68,745 $2.49 Million
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $85,606 - $104,104	-3,722 Reduced 4.11%	86,869 $2.37 Million
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $2.07 Million - $2.58 Million	90,591 New	90,591 $2.18 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Account